Gilenya

Double whammy: Supreme Court slaps down separate bids from Novartis, Sanofi
Fierce Pharma
Tue, 04/18/23 - 09:58 am
legal
Supreme Court
Novartis
Gilenya
Sanofi
Viatris
EpiPens
Novartis loses $940M arbitration case against Mitsubishi Chemical over Gilenya royalties
Fierce Pharma
Mon, 02/20/23 - 12:42 pm
Novartis
Mitsubishi Chemical
multiple sclerosis
MS
Supreme Court
legal
patents
Gilenya
Novartis petitions Supreme Court in effort to 'vigorously defend' Gilenya patent
Endpoints
Tue, 01/24/23 - 06:18 pm
Novartis
Supreme Court
Gilenya
patents
generics
multiple sclerosis
MS
Novartis' blockbuster Gilenya exposed to generics in short term amid Supreme Court appeal
Fierce Pharma
Fri, 10/14/22 - 10:40 am
Novartis
Gilenya
generics
Supreme Court
MS
multiple sclerosis
Facing 'imminent' Gilenya generics and a $300M sales hit, Novartis takes patent fight to Supreme Court
Fierce Pharma
Wed, 09/21/22 - 08:02 pm
Novartis
Supreme Court
Gilenya
patents
legal
MS
Novartis dodges Gilenya kickback claims—again—after whistleblower lawsuit dismissed
Fierce Pharma
Wed, 09/14/22 - 08:04 pm
Novartis
whistleblowers
whistleblower lawsuit
Gilenya
kickbacks
MS
Novartis' MS drug Gilenya could inspire new chronic kidney disease treatment
Fierce Biotech
Fri, 08/19/22 - 10:47 am
Novartis
Gilenya
kidney disease
chronic kidney disease
Novartis' recent Gilenya patent win slips away after appeals court reverses its own prior verdict
Fierce Pharma
Tue, 06/21/22 - 11:45 pm
Novartis
patents
Gilenya
multiple sclerosis
Novartis blocks generic to MS blockbuster Gilenya in US patent dispute
Pharmaforum
Tue, 01/4/22 - 10:50 am
Novartis
Gilenya
patents
HEC Pharma
generics
multiple sclerosis
MS
U.S. court upholds patent for Novartis MS drug Gilenya
Reuters
Tue, 08/18/20 - 11:04 am
Novartis
patents
Gilenya
MS
multiple sclerosis
Early treatment with Novartis' Mayzent stalls secondary progressive MS: study
Fierce Pharma
Tue, 04/21/20 - 11:55 pm
Novartis
Mayzent
MS
multiple sclerosis
Gilenya
Novartis escapes one set of kickback allegations, but federal charges roll on
Fierce Pharma
Wed, 03/25/20 - 11:38 am
Novartis
Gilenya
kickbacks
whistleblower lawsuits
ethics
While Novartis combats generic onslaught in the courts, FDA approves first Gilenya copycats
Endpoints
Fri, 12/6/19 - 09:54 am
Novartis
FDA
Gilenya
MS
multiple sclerosis
Mylan
Dr Reddy's
Torrent Pharmaceuticals
Aurobindo
generics
Novartis multiple sclerosis product Gilenya approved in China
Pharmaceutical Business Review
Mon, 07/22/19 - 09:45 am
China
Novartis
multiple sclerosis
Gilenya
Novartis wins Gilenya reprieve as judge blocks generics, for now
Yahoo/Reuters
Tue, 06/25/19 - 09:20 am
Novartis
generics
Gilenya
multiple sclerosis
Novartis’ Gilenya proves superiority over glatiramer acetate in relapsing remitting MS
Pharmaceutical Business Review
Mon, 05/13/19 - 08:14 pm
Novartis
Gilenya
Relapsing Remitting Multiple Sclerosis
Novartis’ Gilenya gets approval in Europe to treat children and adolescents with MS
Pharmaceutical Business Review
Fri, 11/30/18 - 10:21 am
Novartis
Gilenya
Europe
Relapsing Remitting Multiple Sclerosis
Novartis confident in Gilenya despite FDA call out
Biopharma Dive
Wed, 11/21/18 - 01:09 pm
Novartis
Gilenya
MS
multiple sclerosis
Gilenya beats Copaxone head-to-head at higher dose, study finds
Biopharma Dive
Thu, 10/11/18 - 11:13 pm
Novartis
Teva Pharmaceutical
MS
Copaxone
Gilenya
Novartis' MS patent win also a win for Celgene's impending MS drug: analyst
Medical Marketing and Media
Wed, 07/18/18 - 10:49 pm
Celgene
Novartis
ozanimod
Gilenya
MS
multiple sclerosis
patents

Pages